FDA Inspection 1004334 — Hendrick Regional Blood Center
The FDA completed an inspection of Hendrick Regional Blood Center on Feb 14, 2017 in Abilene, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 14, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Abilene, TX (United States)